Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Biological & Pharmaceutical Bulletin|September 4, 2020
Current Understanding of the Intestinal Absorption of Nucleobases and AnalogsHiroaki Yuasa, Tomoya Yasujima, Katsuhisa Inoue
The Journal of Pharmacology and Experimental Therapeutics|March 20, 2016
Phenobarbital and Insulin Reciprocate Activation of the Nuclear Receptor Constitutive Androstane Receptor through the Insulin ReceptorTomoya Yasujima, Kosuke Saito, Rick Moore, et al.
Life Science Alliance|December 1, 2022
Disrupted in renal carcinoma 2 (DIRC2/SLC49A4) is an H+-driven lysosomal pyridoxine exporterShogo Akino, Tomoya Yasujima, Takahiro Yamashiro, et al.
Journal of Pharmaceutical Sciences|March 26, 2011
Characterization of human OCT1-mediated transport of DAPI as a fluorescent probe substrateTomoya Yasujima, Kinya Ohta, Katsuhisa Inoue, et al.
The Journal of Biological Chemistry|October 3, 2020
pH-dependent pyridoxine transport by SLC19A2 and SLC19A3: Implications for absorption in acidic microclimatesTakahiro Yamashiro, Tomoya Yasujima, Hamid M Said, et al.
Drug Metabolism and Pharmacokinetics|February 10, 2022
Functional characterization of human organic anion transporter 10 (OAT10/SLC22A13) as an orotate transporterYutaro Shinoda, Takahiro Yamashiro, Akira Hosooka, et al.
The Journal of Biological Chemistry|June 20, 2022
Identification of the amino acid residues involved in the species-dependent differences in the pyridoxine transport function of SLC19A3Kohei Miyake, Tomoya Yasujima, Syunsuke Takahashi, et al.
Biochemistry and Biophysics Reports|November 11, 2017
Functional identification of organic cation transporter 1 as an atenolol transporter sensitive to flavonoidsYoshihisa Mimura, Tomoya Yasujima, Kinya Ohta, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2023
Involvement of proton-coupled SLC49A4-mediated transport in the export of lysosomally trapped pyrilamineShogo Akino, Tomoya Yasujima, Rei Shibutani, et al.
Pageof 4